By

Editor

Peral C, de Lossada Juste A, Lwoff N, Espinoza Cámac N, Martínez-Martínez N, Casado MÁ, Burke T, Kane A, Alvir J, Thakkar S, Ferri Grazzi E

 

 

Economic Burden of Moderate and Severe Hemophilia A and B in Spain, Real-World Evidence Insights from the Cost of Hemophilia in Europe: A Socio-Economic Survey II (CHESS II) Study
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023

POSTER

Parramon M, Juárez M, de Pedro S, Echave M, Oyagüez I, Casado MÁ, Martínez-Salamanca JI

 

 

Cost Analysis of Prostav®: A New Telomere-Based Biomarker for the Early Detection of Prostate Cancer Available in Europe
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023

POSTER

Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

 

 

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
ClinicoEconomics and Outcomes Research. 2023:15 659–671